NYSE:ISR

Isoray (ISR) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: N/A
50-Day Range: $0.28
▼
$0.42
52-Week Range: N/A

Volume: 145,000 shs
Average Volume: 290,697 shs
Market Capitalization: $54.57 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Earnings Financials Insider Trades Institutional Ownership Headlines SEC Filings Social Media

About Isoray (NYSE:ISR) Stock

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

April 24, 2023 | thestreet.com

Why IsoRay (ISR) Is Plunging Today

March 16, 2023 | thestreet.com

Why IsoRay (ISR) Stock Is Surging Today

September 22, 2023 | Chaikin Analytics (Ad)

His system isolated NVIDIA - Here's His Next Buy.

Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.

February 16, 2023 | finance.yahoo.com

IsoRay (ISR) Reports Q2 Loss, Misses Revenue Estimates

February 16, 2023 | finance.yahoo.com

Perspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022

February 8, 2023 | finanznachrichten.de

Isoray, Inc.: Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.

February 7, 2023 | finance.yahoo.com

Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.

February 6, 2023 | finance.yahoo.com

Isoray Completes Merger with Viewpoint Molecular Targeting to Advance New Treatment Paradigm in Targeted Precision Oncology Medicine

September 22, 2023 | Chaikin Analytics (Ad)

His system isolated NVIDIA - Here's His Next Buy.

Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.

January 30, 2023 | benzinga.com

Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders

January 30, 2023 | finance.yahoo.com

Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders

January 14, 2023 | thestreet.com

Why IsoRay (ISR) Hit a Five-Year High Today (Update)

January 12, 2023 | finance.yahoo.com

Isoray Announces Adjournment of Annual Meeting of Stockholders to January 27, 2023

December 14, 2022 | finance.yahoo.com

Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2022

December 14, 2022 | finance.yahoo.com

AMENDED: Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2023

December 6, 2022 | proactiveinvestors.com

Isoray's merger with Viewpoint Molecular Targeting sets up big opportunity in 2023

December 6, 2022 | proactiveinvestors.com

Isoray releases Q1 financials as company looks ahead to merger with Viewpoint Molecular Targeting

November 25, 2022 | finance.yahoo.com

Isoray, Inc. (ISR) Stock Historical Prices & Data - Yahoo Finance

November 11, 2022 | finanznachrichten.de

Isoray, Inc.: Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending Merger

November 10, 2022 | seekingalpha.com

Isoray, Inc. (ISR) Q1 2023 Earnings Call Transcript

November 10, 2022 | finance.yahoo.com

Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending Merger

October 31, 2022 | finance.yahoo.com

Isoray To Announce First Quarter Fiscal 2023 Financial Results on November 10, 2022

October 20, 2022 | seekingalpha.com

Isoray Stock: Not Going Anywhere Anytime Soon (NYSE:ISR) - Seeking Alpha

October 18, 2022 | businesswire.com

Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT - Business Wire

October 18, 2022 | finance.yahoo.com

Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT

October 16, 2022 | benzinga.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMBC, BTRS, ISR, JVA - Isoray (AMEX:ISR), BTRS H - Benzinga

October 16, 2022 | globenewswire.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMBC, BTRS, ISR, JVA - GlobeNewswire

See More Headlines

Receive ISR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Isoray and its competitors with MarketBeat's FREE daily newsletter.

ISR Company Calendar

Last Earnings: 11/10/2021
Today: 9/22/2023
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:ISR
CUSIP: N/A
CIK: 728387
Web: isoray.com
Phone: (509) 375-1202
Fax: 509-267-3670
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.07)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-7,270,000.00
Net Margins: -115.91%
Pretax Margin: -91.45%
Return on Equity: -17.12%
Return on Assets: -16.15%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 14.38
Quick Ratio: 13.99

Sales & Book Value

Annual Sales: $10.80 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.43 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 142,110,000
Free Float: 138,674,000
Market Cap: $54.57 million
Optionable: Not Optionable
Beta: 1.48

10 Best Stocks to Own in 2023

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

Lori A. Woods
Chief Executive Officer & Director

Jennifer Streeter
Chief Operating Officer & VP-Human Resources

Mark J. Austin
Co-CFO, Secretary & Chief Accounting Officer

Jonathan R. Hunt
CFO & Principal Financial Officer

William A. Cavanagh
Chief Research & Development Officer

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

ISR Stock - Frequently Asked Questions

How were Isoray's earnings last quarter?: Isoray, Inc. (NYSE:ISR) announced its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.02) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The company earned $2.56 million during the quarter, compared to analysts' expectations of $2.58 million. Isoray had a negative net margin of 115.91% and a negative trailing twelve-month return on equity of 17.12%.
What is Isoray's stock symbol?: Isoray trades on the New York Stock Exchange (NYSE) under the ticker symbol "ISR."
How much money does Isoray make?: Isoray (NYSE:ISR) has a market capitalization of $0.00 and generates $10.80 million in revenue each year. The company earns $-7,270,000.00 in net income (profit) each year or ($0.07) on an earnings per share basis.
How can I contact Isoray?: Isoray's mailing address is 350 HILLS STREET SUITE 106, RICHLAND WA, 99354. The official website for the company is isoray.com. The company can be reached via phone at (509) 375-1202, via email at dbabcock@isoray.com, or via fax at 509-267-3670.

This page (NYSE:ISR) was last updated on 9/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Isoray (ISR) Stock Forecast, Price & News

About Isoray (NYSE:ISR) Stock

ISR Stock News Headlines

ISR Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

ISR Stock - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info